About Us
entrotech life sciences inc
Formed in 2012, entrotech life sciences (ELS) is a privately held materials science company that specializes in thin film technologies. By leveraging the innovation and manufacturing capabilities of the parent company, entrotech, inc., ELS is pioneering chlorhexidine-impregnated film technology.
The entrogroup of companies first introduced non-antimicrobial polymer film technology into tactical combat casualty care products for the United States Military's Special Forces, where its first priority was saving lives. That same mandate has not changed, and ELS has since developed PrevahexCHX to offer an innovative new infection control technology to hospitals worldwide. ELS exists to save lives.
Founder and CEO, Jim McGuire, has more than 75 patents for innovative technologies and processes – all inspired by and directed towards solving real-world problems.
_____
Jim McGuire
President and CEO of entrogroup
Jim McGuire founded entrogroup in 1999 with the vision to solve problems, save lives and provide opportunities for students to learn and grow. After deploying seven advanced life-saving products to battle environments around the world, Jim set out to create a new paradigm in healthcare, creating PrevahexCHX, an inventive chlorhexidine polymer delivery device, in 2014.
Jim currently holds 81 issued and pending patents. He has a BS in chemistry from The Ohio State University where he received an internship with Dupont that changed his goal of achieving a PhD in chemistry to focus on a multifunctional career based on the combination of business and science. At Ohio State University he serves on the Technology Oversight Committee for the Department of Chemistry and on the advisory board for the Institute of Materials Research.
Jim and his family live in Palm Beach, Florida, for nine months of the year, and spend their summers in Columbus, Ohio. He has a passion for motorsports, and currently drives an LMP3 in the Michelin Le Mans Cup in Europe.
Meet the Leadership Team
Tom Semans
president
Tom Semans
President
Tom Semans serves as the President of the entrogroup Companies, including entrotech life sciences. Tom has over 40 years experience in the chemical and material science industries. He has served as President & Chief Operating Officer of a company with international operations, as well as numerous executive positions with Ashland Chemical. His experiences include general management, commitment to safety & compliance, strategy development, marketing, sales, technology development, manufacturing, quality & continuous improvement, finance, people development and mergers & acquisitions. Tom has helped grow high functioning businesses, turned around unprofitable businesses, created and grown start-ups and helped drive healthy business cultures resulting in sustainable profitability. Tom has a Bachelor of Science in Business Administration from Miami University.
Bob Lutkewitte
vice president of sales
Bob Lutkewitte
Vice-President, Sales
Bob Lutkewitte serves as the Senior Vice President of Sales at entrotech life sciences inc. He is an accomplished professional with over 25 years of experience in the healthcare industry directing international, national and regional sales and marketing organizations. He has worked with companies such as Boyd Corporation, IrOs LLC, Centurion Medical Products, Inc. and Enturia, Inc. Bob holds a Bachelor of Science in Accountancy from Villanova University and an Executive MBA Series from Kellogg Graduate School of Business at Northwestern University.
Dr. George Holinga
chief technology officer
George Holinga, Ph.D., RAC
Chief Technology Officer
Dr. George Holinga serves as the Chief Technology Officer at entrotech life sciences inc. where he has played a significant role in the development and execution of its product portfolio since 2010. Prior to entrotech life sciences, George worked as a graduate student research assistant at Lawrence Berkeley National Laboratory, investigating the surface science of biomaterials. He has also served as a scientific consultant working on the development of prototype blood purification therapy products.
George holds a Ph.D. in physical chemistry from the University of California, Berkeley and a Bachelor of Science in both chemistry and physics from Ohio State University. He has published multiple peer-reviewed articles on topics ranging from biomolecular surface science to the development of new, non-linear spectroscopic techniques.